Mark Kendall: Demo: A needle-free vaccine patch that's safer and way cheaper
Mark Kendall: Demonstracija: Cjepivo bez igle u obliku flastera koje je sigurnije i mnogo jeftinije
Mark Kendall aims to shake up how vaccines are delivered with the Nanopatch. Full bio
Double-click the English transcript below to play the video.
Kraljevskom koledžu liječnika.
i danas kad ga pogledam
skoro identično
this 160-year-old technology.
starom tehnologijom.
na mnogo razina,
je najviše pridonijela
fobija od igala.
da ne volite igle;
of the rollout of vaccines.
primjene cjepiva.
umre godišnje
you probably may have heard of,
may not have heard about.
mogle usporiti razvoj
tehnologija mogla biti odgovorna
that I'll tell you about as well.
o kojem ću vam također govoriti.
tackle those four problems.
trebala baviti s ova četiri problema.
work with the skin's immune system.
da rade zajedno s imunosnim sustavom kože.
is one that's been borrowed
the projections of the Nanopatch
suhom stanju na ispupčenja Nanoflastera
the Nanopatch to the skin as so --
Nanoflaster na kožu --
manje od jedne minute.
a reuse of the applicator itself.
ponovno koristiti.
o tome kako radi Nanoflaster,
izbacili iglu --
ne možete vidjeti --
responses through delivery,
zahvaljujući provedbi,
this immunogenicity idea.
s idejom imunogenosti.
shvatite ovaj pojam
kako cjepiva funkcioniraju.
u tijelo unosimo
how to deal with intruders.
with the needle and syringe,
is holding back our immune responses;
zapravo sputava našu imunosnu reakciju;
najučinkovitiji dio na našoj koži.
predodžbu o proporcijama,
ona bi bila prevelika.
going 10 times deeper as well.
bi i prodirala 10 puta dublje.
have those projections in the skin.
ispupčenja u koži.
vanjski sloj mrtve kože,
called a Langerhans cell --
koju nazivamo Langerhans stanica --
there's others shown as well
i druge stanice
of these particular cells
površinskog sloja kože
this thing and designed it to do that,
dizajnirao je da čini sve ovo,
ne možete zaista znati
imunosnu reakciju
ubodom igle i šprice u mišić.
the dose shown in nanograms.
doza u nanogramima.
the immune response generated,
dobivena imunosna reakcija,
the protection threshold.
zaštitnosti cjepiva.
cjepivo se smatra zaštitnim;
onda nije.
nalazi ispod te krivulje
is achieved with the needle that's protective,
dobivena metodom igle zaštitna
that works but is too expensive
je djelotvorno ali preskupo
compared to the needle.
trebali uzeti kad bismo koristili iglu.
10 dollars down to 10 cents,
koje košta 10$ padne na samo10 centi,
within the developing world.
u razvoju.
7 million deaths per year,
7 milijuna smrti godišnje,
method for any of those.
za bilo koju od njih.
that we have with the Nanopatch,
koju imamo zahvaljujući Nanoflasteru
candidate vaccines over the line.
potencijalnim cjepivima prijeći tu liniju.
cjepivo protiv gripe.
a vaccine right from production
od proizvodnje
hladni lanac.
previsokim temperaturama
izloženo i preniskim temperaturama
procjenjuje da u Africi
cold chain has fallen over.
prekinuo hladni lanac .
in with the needle and syringe
a usko je povezan s korištenjem igle i šprice
when it's liquid it needs the refrigeration.
a u tom slučaju cjepivo treba zamrzavati.
any loss in activity at all.
bez gubitka razine aktivnosti.
we have well and truly proven
jest da smo zaista dokazali
laboratorijskom okruženju.
out, taken it out of the lab
ne izađemo iz laboratorija
journey in an unusual way.
of a developing world country.
refrigerators to keep vaccines chilled.
hladnjaka u kojima se čuvaju cjepiva.
many of them are breaking down
mnogi se kvare,
where they are required.
gdje su prijeko potrebni.
world's highest incidence of HPV,
pojave HPV-a,
cervical cancer [risk factor].
[činitelj rizika] u svijetu.
the attributes of the Nanopatch,
karakterstikama Nanoflastera,
worked with the Nanopatch,
raditi s Nanoflasterom
the world I'd rather be doing.
zaraznih bolesti
of being needle-free, pain-free,
kojemu su glavne osobine
to što smo se riješili igle i boli,
and improving the immunogenicity.
potreba za hladnim lancem
i da se poboljša imunogenost.
ABOUT THE SPEAKER
Mark Kendall - Biomedical engineerMark Kendall aims to shake up how vaccines are delivered with the Nanopatch.
Why you should listen
Looking a bit like a fuzzy computer chip, the Nanopatch uses tiny powder-coated spikes to deliver a small dose of vaccine just under the skin, immunizing a person in about a minute. Made for less than $1, it uses only a fraction of a vaccine dose delivered by traditional syringe method (which was invented in 1853), at the same time eliminating the risk of needle injuries. What’s more, a Nanopatch infused with vaccine is designed to be heat-stable, so it can be transported without refrigeration. And the process doesn't draw blood, reducing the risk of infections.
Mark Kendall, an Australian biomedical engineer, was part of a team at the University of Queensland that advanced the Nanopatch by vaccinating animals. Now his company, Vaxxas, is on a mission to commercialize the device for human use. He plans to run an international trial using the Nanopatch, starting with the human papilloma virus (HPV) vaccine to protect against cervical cancer.
Mark Kendall | Speaker | TED.com